XML 123 R115.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidating Financial Information (Details 5) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2012
Jun. 30, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Condensed Consolidating Statements Of Cash Flows          
Net cash provided by (used for) operating activities $ 244,183 $ 711,937 $ 1,418,223 $ 1,562,705 $ 1,456,487
Cash flows from investing activities:          
Purchases of investments       (949) (11,746)
Sales and maturities of investments     164,510 31,944 39,063
Proceeds from sale of unconsolidated affiliates     12,640 159,529 142,984
Cash paid for acquisition of businesses, net     (116,971)   (55,459)
Investment in unconsolidated affiliates     (5,967) (1,325) (112,262)
Capital expenditures     (1,178,205) (1,518,628) (2,042,617)
Proceeds from sales of assets and insurance claims     308,538 149,801 180,558
Other     (13)    
Net cash used for investing activities     (815,468) (1,179,628) (1,859,479)
Cash flows from financing activities:          
Increase (decrease) in cash overdrafts     (4,421) 1,612 6,375
Proceeds from issuance of long-term debt     698,753    
Debt issuance costs     (4,500) (3,433) (7,141)
Proceeds from revolving credit facilities       710,000 1,560,000
Proceeds from (payments for) issuance of common shares     5,383 (3,625) 11,605
Reduction in long-term debt     (994,181) (276,258) (1,404,281)
Dividends to shareholders     (47,168)    
Proceeds (reductions) in commercial paper, net     329,844    
Reduction in revolving credit facilities     (720,000) (680,000) (700,000)
Repurchase of equity component of convertible debt         (12)
Purchase of restricted stock       (2,160) (2,626)
Tax benefit related to share-based awards       (263) 1,747
Other     6,704 (2,423) (891)
Net cash (used for) provided by financing activities     (729,586) (254,127) 163,245
Effect of exchange rate changes on cash and cash equivalents     (8,176) (2,603) (3,380)
Net increase (decrease) in cash and cash equivalents     (135,007) 126,347 (243,127)
Cash and cash equivalents, beginning of period 398,575 398,575 524,922 398,575 641,702
Cash and cash equivalents, end of period     389,915 524,922 398,575
Nabors (Parent/Guarantor)
         
Condensed Consolidating Statements Of Cash Flows          
Net cash provided by (used for) operating activities     16,746 7,253 6,612
Cash flows from investing activities:          
Cash paid for acquisition of businesses, net       (35)  
Cash paid for investments in consolidated affiliates     (100)   (26,235)
Net cash used for investing activities     (100) (35) (26,235)
Cash flows from financing activities:          
Proceeds from (payments for) issuance of common shares     37,455 (3,622) 11,605
Dividends to shareholders     (51,713)    
Other     (3,296) (2,160) (2,626)
Net cash (used for) provided by financing activities     (17,554) (5,782) 8,979
Net increase (decrease) in cash and cash equivalents     (908) 1,436 (10,644)
Cash and cash equivalents, beginning of period 203 203 1,639 203 10,847
Cash and cash equivalents, end of period     730 1,639 203
Nabors Delaware (Issuer/Guarantor)
         
Condensed Consolidating Statements Of Cash Flows          
Net cash provided by (used for) operating activities     (157,952) 39,708 (109,125)
Cash flows from investing activities:          
Cash paid for investments in consolidated affiliates     (772,000)   (65,000)
Changes in intercompany balances     748,537 274,482 77,947
Net cash used for investing activities     (23,463) 274,482 12,947
Cash flows from financing activities:          
Proceeds from issuance of long-term debt     698,434   697,578
Debt issuance costs     (4,500) (3,433) (7,141)
Proceeds from revolving credit facilities       710,000 1,510,000
Reduction in long-term debt     (994,112) (224,997) (1,404,246)
Dividends to shareholders       9,003  
Proceeds (reductions) in commercial paper, net     329,844    
Reduction in revolving credit facilities     (720,000) (680,000) (700,000)
Proceeds from parent contributions     772,000    
Other         (12)
Net cash (used for) provided by financing activities     81,666 (207,433) 96,179
Net increase (decrease) in cash and cash equivalents     (99,749) 106,757 1
Cash and cash equivalents, beginning of period 21 21 106,778 21 20
Cash and cash equivalents, end of period     7,029 106,778 21
Other Subsidiaries (Non-Guarantors)
         
Condensed Consolidating Statements Of Cash Flows          
Net cash provided by (used for) operating activities     1,531,902 1,546,250 1,559,000
Cash flows from investing activities:          
Purchases of investments       (949) (11,746)
Sales and maturities of investments     164,510 31,944 39,063
Proceeds from sale of unconsolidated affiliates     12,640 159,529 142,984
Cash paid for acquisition of businesses, net     (116,971)   (55,459)
Investment in unconsolidated affiliates     (5,967) (1,325) (112,262)
Capital expenditures     (1,178,205) (1,518,628) (2,042,617)
Proceeds from sales of assets and insurance claims     308,538 149,801 180,558
Cash paid for investments in consolidated affiliates     (1,544,000)    
Other     (13)    
Changes in intercompany balances     (748,537) (274,482) (77,947)
Net cash used for investing activities     (3,108,005) (1,454,110) (1,937,426)
Cash flows from financing activities:          
Increase (decrease) in cash overdrafts     (4,421) 1,612 6,375
Proceeds from issuance of long-term debt     319    
Proceeds from revolving credit facilities         50,000
Proceeds from (payments for) issuance of common shares       (3)  
Reduction in long-term debt     (69) (51,261) (35)
Dividends to shareholders       21,503  
Proceeds from parent contributions     1,544,100 35 91,235
Other     10,000 (263) 1,747
Net cash (used for) provided by financing activities     1,549,929 (71,383) 149,322
Effect of exchange rate changes on cash and cash equivalents     (8,176) (2,603) (3,380)
Net increase (decrease) in cash and cash equivalents     (34,350) 18,154 (232,484)
Cash and cash equivalents, beginning of period 398,351 398,351 416,505 398,351 630,835
Cash and cash equivalents, end of period     382,156 416,505 398,351
Consolidating Adjustments
         
Condensed Consolidating Statements Of Cash Flows          
Net cash provided by (used for) operating activities     27,527 (30,506)  
Cash flows from investing activities:          
Cash paid for acquisition of businesses, net       35  
Cash paid for investments in consolidated affiliates     2,316,100   91,235
Net cash used for investing activities     2,316,100 35 91,235
Cash flows from financing activities:          
Proceeds from (payments for) issuance of common shares     (32,072)    
Dividends to shareholders     (4,545) (30,506)  
Proceeds from parent contributions     (2,316,100) (35) (91,235)
Net cash (used for) provided by financing activities     $ (2,343,627) $ 30,471 $ (91,235)